| 1 |
陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J]. 中华内科杂志, 2006, 45(6):441-442.
|
| 2 |
Moranne O, Froissart M,Rossert J, et al. Timing of onset of CKDRelated metabolic complications[J]. J Am Soc Nephrol, 2009, 20(1):164-171.
|
| 3 |
Covic A,Kothawala P,Bernal M,et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality,cardiovascular mortality and cardiovascular events in chronic kidney disease[J]. Nephrol Dial Transplant,2009,24(5):1506-1523.
|
| 4 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis,evaluation, prevention, and treatment of chronic kidney diseasemineral and bone disorder (CKD-MBD) [J]. Kidney Int,2009,76(Suppl 113):S1-130.
|
| 5 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int, 2013, 3 Suppl 1:1-150.
|
| 6 |
Regidor DL, Kovesdy CP, Mehrotra R, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients [J]. J Am Soc Nephrol,2008,19(11):2193-2203.
|
| 7 |
Barreto FC,Barreto DV,Moyses RM,et al. K /DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients[J].Kidney Int,2008,73(6):771-777.
|
| 8 |
Teresa A, Joao MF. Cardiovascular risk in dialysis patients: X-ray vision on vascular calfications[J]. Kidney Int, 2008, 74(12):1505-1507.
|
| 9 |
Benini O,D'Alessandro C,Gianfaldoni D,et al. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients[J]. J Ren Nutr,2011,21(4):303-308.
|
| 10 |
Cupisti A,D'Alessandro C. The impact of known and unknown dietary components to phosphorus intake[J].G Ital Nefrol,2011,28(3):278-288.
|
| 11 |
Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phos-phorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease[J].Am J Clin Nutr,2008,88(6):1511-1518.
|
| 12 |
Russo D,Miranda I,Ruocco C,et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer[J]. Kidney Int,2007,72(10):1255-1261.
|
| 13 |
Koiwa F,Kazama JJ,Tokumoto A,et al. Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients[J]. Ther Apher Dial,2005,9 (4):336-339.
|
| 14 |
Oliveira RB,Cancela AL,Graciolli FG,et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy [J]. Clin J Am Soc Nephrol,2010,5(2):286-291.
|
| 15 |
Isakova T,Xie H,Yang W,et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease[J]. JAMA,2011,305(23):2432-2439.
|
| 16 |
Daugirdas JT,Finn WF,Emmett M,et al. The phosphate binder equivalent dose[J].Semin Dial,2011,24(1):41-49.
|
| 17 |
Navaneethan SD,Palmer SC,Vecchio M,et al. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients[J].Cochrane Database Syst Rev,2011,16(2): CD006023.
|
| 18 |
Penne EL,van der Weerd NC,van den Dorpel MA,et al. Short-term effects of online hemodiafiltration on phosphate control:a result from the randomized controlled convective transport study (CONTRAST)[J].Am J Kidney Dis,2010,55(1):77-87.
|
| 19 |
Walsh M,Manns B J,Klarenbach S,et al. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial [ J]. Hemodial Int, 2010, 14 (2):174-181.
|
| 20 |
Tentori F. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS[J]. Semin Dial,2010, 23(1):10-14.
|
| 21 |
顾波,路建饶. 尿毒症中高磷和心血管钙化研究新进展[J]. 国际泌尿系统杂志,2006,26(4):566-568.
|
| 22 |
Frazao JM, Martins P. Adynamic bone disease: clinical and ther-apeutic implications. Curr Opin Nephrol Hypertens,2009,18(4):303-307.
|
| 23 |
Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring gas6-axl survival pathway[J]. CircRes,2006,98(8):1024-1031.
|
| 24 |
石玥,张宁,刘世巍,等.补肾活血法治疗肾性骨病60 例临床观察[J]. 北京中医药大学学报,2010,33(11):782-785.
|
| 25 |
韩佳瑞,左振魁,张琪,等.慢性肾衰竭中医辨证分型与血清钙、磷水平的关系[J].光明中医,2011,26(8):1570-1571.
|
| 26 |
安海燕,任可.补骨汤治疗肾性骨病的临床观察[J]. 中国中西医结合肾病杂志,2004,5(12):718-719.
|
| 27 |
许文娟,李秋景,黄雪红,等.益骨散治疗慢性肾功能不全失代偿期合并肾性骨病20 例[J].环球中医药,2011,4(6):473-474.
|